SPONSORED CONTENT The landscape of clinical trials, particularly within the challenging sphere of rare diseases, is undergoing a necessary and profound evolution. No longer is the patient merely a passive subject; they are emerging as an essential, co-equal partner in the design process. This paradigm shift, often termed “co-design”, was the focus of a critical … Continue reading The co-design revolution: how empowering patients is the future of clinical trials